Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.

Erickson ML, Haus JM, Malin SK, Flask CA, McCullough AJ, Kirwan JP.

Nutr Metab Cardiovasc Dis. 2019 Jun 21. pii: S0939-4753(19)30240-6. doi: 10.1016/j.numecd.2019.06.012. [Epub ahead of print]

PMID:
31371265
2.

Increased cerebral vascularization and decreased water exchange across the blood-brain barrier in aquaporin-4 knockout mice.

Zhang Y, Xu K, Liu Y, Erokwu BO, Zhao P, Flask CA, Ramos-Estebanez C, Farr GW, LaManna JC, Boron WF, Yu X.

PLoS One. 2019 Jun 20;14(6):e0218415. doi: 10.1371/journal.pone.0218415. eCollection 2019.

3.

Functionalized Phenylbenzamides Inhibit Aquaporin-4 Reducing Cerebral Edema and Improving Outcome in Two Models of CNS Injury.

Farr GW, Hall CH, Farr SM, Wade R, Detzel JM, Adams AG, Buch JM, Beahm DL, Flask CA, Xu K, LaManna JC, McGuirk PR, Boron WF, Pelletier MF.

Neuroscience. 2019 Apr 15;404:484-498. doi: 10.1016/j.neuroscience.2019.01.034. Epub 2019 Feb 7.

PMID:
30738082
4.

Stromal derived factor-1 plasmid as a novel injection for treatment of stress urinary incontinence in a rat model.

Khalifa AO, Kavran M, Mahran A, Isali I, Woda J, Flask CA, Penn MS, Hijaz AK.

Int Urogynecol J. 2019 Jan 21. doi: 10.1007/s00192-019-03867-3. [Epub ahead of print]

PMID:
30666428
5.

Small adipose stores in cystic fibrosis mice are characterized by reduced cell volume, not cell number.

Bederman I, DiScenna A, Henderson L, Perez A, Klavanian J, Kovtun D, Collins O, Dunn J, Erokwu B, Flask CA, Drumm ML.

Am J Physiol Gastrointest Liver Physiol. 2018 Dec 1;315(6):G943-G953. doi: 10.1152/ajpgi.00096.2017. Epub 2018 Sep 6.

PMID:
30188751
6.

Absence of leptin signaling allows fat accretion in cystic fibrosis mice.

Bederman IR, Pora G, O'Reilly M, Poleman J, Spoonhower K, Puchowicz M, Perez A, Erokwu BO, Rodriguez-Palacios A, Flask CA, Drumm ML.

Am J Physiol Gastrointest Liver Physiol. 2018 Nov 1;315(5):G685-G698. doi: 10.1152/ajpgi.00344.2017. Epub 2018 Aug 17.

PMID:
30118352
7.

Nanosensors for the Chemical Imaging of Acetylcholine Using Magnetic Resonance Imaging.

Luo Y, Kim EH, Flask CA, Clark HA.

ACS Nano. 2018 Jun 26;12(6):5761-5773. doi: 10.1021/acsnano.8b01640. Epub 2018 Jun 6.

8.

Fast magnetic resonance fingerprinting for dynamic contrast-enhanced studies in mice.

Gu Y, Wang CY, Anderson CE, Liu Y, Hu H, Johansen ML, Ma D, Jiang Y, Ramos-Estebanez C, Brady-Kalnay S, Griswold MA, Flask CA, Yu X.

Magn Reson Med. 2018 Dec;80(6):2681-2690. doi: 10.1002/mrm.27345. Epub 2018 May 9.

PMID:
29744935
9.

A novel synthetic route for high-index faceted iron oxide concave nanocubes with high T2 relaxivity for in vivo MRI applications.

Situ-Loewenstein SF, Wickramasinghe S, Abenojar EC, Erokwu BO, Flask CA, Lee Z, Samia ACS.

J Mater Sci Mater Med. 2018 May 5;29(5):58. doi: 10.1007/s10856-018-6052-6.

10.

Quantitative magnetic resonance imaging assessments of autosomal recessive polycystic kidney disease progression and response to therapy in an animal model.

Erokwu BO, Anderson CE, Flask CA, Dell KM.

Pediatr Res. 2018 May;83(5):1067-1074. doi: 10.1038/pr.2018.24. Epub 2018 May 2.

PMID:
29538364
11.

Diffusion tensor imaging MRI of sickle cell kidney disease: initial results and comparison with iron deposition.

Donnola SB, Piccone CM, Lu L, Batesole J, Little J, Dell KM, Flask CA.

NMR Biomed. 2018 Mar;31(3). doi: 10.1002/nbm.3883. Epub 2018 Jan 19.

12.

Dual Contrast - Magnetic Resonance Fingerprinting (DC-MRF): A Platform for Simultaneous Quantification of Multiple MRI Contrast Agents.

Anderson CE, Donnola SB, Jiang Y, Batesole J, Darrah R, Drumm ML, Brady-Kalnay SM, Steinmetz NF, Yu X, Griswold MA, Flask CA.

Sci Rep. 2017 Aug 16;7(1):8431. doi: 10.1038/s41598-017-08762-9.

13.

Regularly incremented phase encoding - MR fingerprinting (RIPE-MRF) for enhanced motion artifact suppression in preclinical cartesian MR fingerprinting.

Anderson CE, Wang CY, Gu Y, Darrah R, Griswold MA, Yu X, Flask CA.

Magn Reson Med. 2018 Apr;79(4):2176-2182. doi: 10.1002/mrm.26865. Epub 2017 Aug 10.

14.

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis.

Gupta K, Donnola SB, Sadeghi Z, Lu L, Erokwu BO, Kavran M, Hijaz A, Flask CA.

J Vis Exp. 2017 Jul 18;(125). doi: 10.3791/54649.

15.

The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.

Schugar RC, Shih DM, Warrier M, Helsley RN, Burrows A, Ferguson D, Brown AL, Gromovsky AD, Heine M, Chatterjee A, Li L, Li XS, Wang Z, Willard B, Meng Y, Kim H, Che N, Pan C, Lee RG, Crooke RM, Graham MJ, Morton RE, Langefeld CD, Das SK, Rudel LL, Zein N, McCullough AJ, Dasarathy S, Tang WHW, Erokwu BO, Flask CA, Laakso M, Civelek M, Naga Prasad SV, Heeren J, Lusis AJ, Hazen SL, Brown JM.

Cell Rep. 2017 Jul 5;20(1):279. doi: 10.1016/j.celrep.2017.06.053. No abstract available.

16.

The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.

Schugar RC, Shih DM, Warrier M, Helsley RN, Burrows A, Ferguson D, Brown AL, Gromovsky AD, Heine M, Chatterjee A, Li L, Li XS, Wang Z, Willard B, Meng Y, Kim H, Che N, Pan C, Lee RG, Crooke RM, Graham MJ, Morton RE, Langefeld CD, Das SK, Rudel LL, Zein N, McCullough AJ, Dasarathy S, Tang WHW, Erokwu BO, Flask CA, Laakso M, Civelek M, Naga Prasad SV, Heeren J, Lusis AJ, Hazen SL, Brown JM.

Cell Rep. 2017 Jun 20;19(12):2451-2461. doi: 10.1016/j.celrep.2017.05.077. Erratum in: Cell Rep. 2017 Jul 5;20(1):279.

17.

Improved Growth Patterns in Cystic Fibrosis Mice after Loss of Histone Deacetylase 6.

Rymut SM, Corey DA, Valerio DM, Erokwu BO, Flask CA, Kelley TJ, Hodges CA.

Sci Rep. 2017 Jun 16;7(1):3676. doi: 10.1038/s41598-017-03931-2.

18.

Quantitative Molecular Imaging with a Single Gd-Based Contrast Agent Reveals Specific Tumor Binding and Retention in Vivo.

Johansen ML, Gao Y, Hutnick MA, Craig SEL, Pokorski JK, Flask CA, Brady-Kalnay SM.

Anal Chem. 2017 Jun 6;89(11):5932-5939. doi: 10.1021/acs.analchem.7b00384. Epub 2017 May 22.

19.

Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.

Maier C, Schadock I, Haber PK, Wysocki J, Ye M, Kanwar Y, Flask CA, Yu X, Hoit BD, Adams GN, Schmaier AH, Bader M, Batlle D.

J Mol Med (Berl). 2017 May;95(5):473-486. doi: 10.1007/s00109-017-1513-9. Epub 2017 Feb 3.

PMID:
28160049
20.

Hyperammonaemia-induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress.

Davuluri G, Allawy A, Thapaliya S, Rennison JH, Singh D, Kumar A, Sandlers Y, Van Wagoner DR, Flask CA, Hoppel C, Kasumov T, Dasarathy S.

J Physiol. 2016 Dec 15;594(24):7341-7360. doi: 10.1113/JP272796. Epub 2016 Oct 23.

21.

Dynamic Quantitative T1 Mapping in Orthotopic Brain Tumor Xenografts.

Herrmann K, Erokwu BO, Johansen ML, Basilion JP, Gulani V, Griswold MA, Flask CA, Brady-Kalnay SM.

Transl Oncol. 2016 Apr;9(2):147-154. doi: 10.1016/j.tranon.2016.02.004.

22.

Obesity-initiated metabolic syndrome promotes urinary voiding dysfunction in a mouse model.

He Q, Babcook MA, Shukla S, Shankar E, Wang Z, Liu G, Erokwu BO, Flask CA, Lu L, Daneshgari F, MacLennan GT, Gupta S.

Prostate. 2016 Aug;76(11):964-76. doi: 10.1002/pros.23185. Epub 2016 Apr 4.

23.

Short-term aerobic exercise training improves gut peptide regulation in nonalcoholic fatty liver disease.

Kullman EL, Kelly KR, Haus JM, Fealy CE, Scelsi AR, Pagadala MR, Flask CA, McCullough AJ, Kirwan JP.

J Appl Physiol (1985). 2016 May 15;120(10):1159-64. doi: 10.1152/japplphysiol.00693.2015. Epub 2016 Mar 31.

24.

Preliminary comparison of normalized T1 and non-contrast perfusion MRI assessments of regional lung disease in cystic fibrosis patients.

Donnola SB, Dasenbrook EC, Weaver D, Lu L, Gupta K, Prabhakaran A, Yu X, Chmiel JF, McBennett K, Konstan MW, Drumm ML, Flask CA.

J Cyst Fibros. 2017 Mar;16(2):283-290. doi: 10.1016/j.jcf.2015.11.009. Epub 2015 Dec 22.

25.

Initial evaluation of hepatic T1 relaxation time as an imaging marker of liver disease associated with autosomal recessive polycystic kidney disease (ARPKD).

Gao Y, Erokwu BO, DeSantis DA, Croniger CM, Schur RM, Lu L, Mariappuram J, Dell KM, Flask CA.

NMR Biomed. 2016 Jan;29(1):84-9. doi: 10.1002/nbm.3442. Epub 2015 Nov 26.

26.

Mesenchymal stem cell therapy in a rat model of birth-trauma injury: functional improvements and biodistribution.

Sadeghi Z, Isariyawongse J, Kavran M, Izgi K, Marini G, Molter J, Daneshgari F, Flask CA, Caplan A, Hijaz A.

Int Urogynecol J. 2016 Feb;27(2):291-300. doi: 10.1007/s00192-015-2831-5. Epub 2015 Sep 9.

27.

The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response.

Jiang K, Jiao S, Vitko M, Darrah R, Flask CA, Hodges CA, Yu X.

J Cyst Fibros. 2016 Jan;15(1):34-42. doi: 10.1016/j.jcf.2015.06.003. Epub 2015 Jun 25.

28.

Preclinical MR fingerprinting (MRF) at 7 T: effective quantitative imaging for rodent disease models.

Gao Y, Chen Y, Ma D, Jiang Y, Herrmann KA, Vincent JA, Dell KM, Drumm ML, Brady-Kalnay SM, Griswold MA, Flask CA, Lu L.

NMR Biomed. 2015 Mar;28(3):384-94. doi: 10.1002/nbm.3262. Epub 2015 Feb 2.

29.

Synthesis, characterization, and X-ray attenuation properties of ultrasmall BiOI nanoparticles: toward renal clearable particulate CT contrast agents.

Kandanapitiye MS, Gao M, Molter J, Flask CA, Huang SD.

Inorg Chem. 2014 Oct 6;53(19):10189-94. doi: 10.1021/ic5011709. Epub 2014 Sep 9.

30.

Biocompatible nanoparticles of KGd(H₂O)₂[Fe(CN)₆]·H₂O with extremely high T₁-weighted relaxivity owing to two water molecules directly bound to the Gd(III) center.

Perera VS, Yang LD, Hao J, Chen G, Erokwu BO, Flask CA, Zavalij PY, Basilion JP, Huang SD.

Langmuir. 2014 Oct 14;30(40):12018-26. doi: 10.1021/la501985p. Epub 2014 Oct 3.

31.

Lack of dystrophin results in abnormal cerebral diffusion and perfusion in vivo.

Goodnough CL, Gao Y, Li X, Qutaish MQ, Goodnough LH, Molter J, Wilson D, Flask CA, Yu X.

Neuroimage. 2014 Nov 15;102 Pt 2:809-16. doi: 10.1016/j.neuroimage.2014.08.053. Epub 2014 Sep 7.

32.

Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): a randomized trial in obese endometrial cancer survivors.

Nock NL, Dimitropoulos A, Rao SM, Flask CA, Schluchter M, Zanotti KM, Rose PG, Kirwan JP, Alberts J.

Contemp Clin Trials. 2014 Nov;39(2):236-45. doi: 10.1016/j.cct.2014.08.008. Epub 2014 Aug 17.

33.

Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.

Babcook MA, Shukla S, Fu P, Vazquez EJ, Puchowicz MA, Molter JP, Oak CZ, MacLennan GT, Flask CA, Lindner DJ, Parker Y, Daneshgari F, Gupta S.

Mol Cancer Ther. 2014 Oct;13(10):2288-302. doi: 10.1158/1535-7163.MCT-14-0451. Epub 2014 Aug 13.

34.

Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression.

Yori JL, Lozada KL, Seachrist DD, Mosley JD, Abdul-Karim FW, Booth CN, Flask CA, Keri RA.

Cancer Res. 2014 Sep 1;74(17):4762-71. doi: 10.1158/0008-5472.CAN-13-3627. Epub 2014 Jul 14.

35.

Arterial spin labeling-fast imaging with steady-state free precession (ASL-FISP): a rapid and quantitative perfusion technique for high-field MRI.

Gao Y, Goodnough CL, Erokwu BO, Farr GW, Darrah R, Lu L, Dell KM, Yu X, Flask CA.

NMR Biomed. 2014 Aug;27(8):996-1004. doi: 10.1002/nbm.3143. Epub 2014 Jun 3.

36.

Lipid elimination with an echo-shifting N/2-ghost acquisition (LEENA) MRI.

Lu L, Donnola SB, Koontz M, Griswold MA, Duerk JL, Flask CA.

Magn Reson Med. 2015 Feb;73(2):711-7. doi: 10.1002/mrm.25177. Epub 2014 Mar 17.

37.

Hepatic fat during fasting and refeeding by MRI fat quantification.

Narayan S, Flask CA, Kalhan SC, Wilson DL.

J Magn Reson Imaging. 2015 Feb;41(2):347-53. doi: 10.1002/jmri.24616. Epub 2014 Mar 3.

38.

Normalized T1 magnetic resonance imaging for assessment of regional lung function in adult cystic fibrosis patients--a cross-sectional study.

Dasenbrook EC, Lu L, Donnola S, Weaver DE, Gulani V, Jakob PM, Konstan MW, Flask CA.

PLoS One. 2013 Sep 25;8(9):e73286. doi: 10.1371/journal.pone.0073286. eCollection 2013.

39.

Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease.

Malin SK, Mulya A, Fealy CE, Haus JM, Pagadala MR, Scelsi AR, Huang H, Flask CA, McCullough AJ, Kirwan JP.

J Appl Physiol (1985). 2013 Oct 1;115(7):988-94. doi: 10.1152/japplphysiol.00237.2013. Epub 2013 Aug 8.

40.

Device localization and dynamic scan plane selection using a wireless magnetic resonance imaging detector array.

Riffe MJ, Yutzy SR, Jiang Y, Twieg MD, Blumenthal CJ, Hsu DP, Pan L, Gilson WD, Sunshine JL, Flask CA, Duerk JL, Nakamoto D, Gulani V, Griswold MA.

Magn Reson Med. 2014 Jun;71(6):2243-9. doi: 10.1002/mrm.24853. Epub 2013 Jul 30.

41.

Improved hepatic lipid composition following short-term exercise in nonalcoholic fatty liver disease.

Haus JM, Solomon TP, Kelly KR, Fealy CE, Kullman EL, Scelsi AR, Lu L, Pagadala MR, McCullough AJ, Flask CA, Kirwan JP.

J Clin Endocrinol Metab. 2013 Jul;98(7):E1181-8. doi: 10.1210/jc.2013-1229. Epub 2013 Apr 24.

42.

Myelin antigen load influences antigen presentation and severity of central nervous system autoimmunity.

Jaini R, Popescu DC, Flask CA, Macklin WB, Tuohy VK.

J Neuroimmunol. 2013 Jun 15;259(1-2):37-46. doi: 10.1016/j.jneuroim.2013.03.012. Epub 2013 Apr 17.

43.

Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents.

Bruckman MA, Hern S, Jiang K, Flask CA, Yu X, Steinmetz NF.

J Mater Chem B. 2013 Mar 14;1(10):1482-1490.

44.

A low-glycemic diet lifestyle intervention improves fat utilization during exercise in older obese humans.

Solomon TP, Haus JM, Cook MA, Flask CA, Kirwan JP.

Obesity (Silver Spring). 2013 Nov;21(11):2272-8. doi: 10.1002/oby.20411. Epub 2013 Jun 11.

45.

Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis.

Dixon LJ, Flask CA, Papouchado BG, Feldstein AE, Nagy LE.

PLoS One. 2013;8(2):e56100. doi: 10.1371/journal.pone.0056100. Epub 2013 Feb 7.

46.

Imaging metastasis using an integrin-targeting chain-shaped nanoparticle.

Peiris PM, Toy R, Doolittle E, Pansky J, Abramowski A, Tam M, Vicente P, Tran E, Hayden E, Camann A, Mayer A, Erokwu BO, Berman Z, Wilson D, Baskaran H, Flask CA, Keri RA, Karathanasis E.

ACS Nano. 2012 Oct 23;6(10):8783-95. doi: 10.1021/nn303833p. Epub 2012 Sep 24.

47.

¹⁹F MRI tracer preserves in vitro and in vivo properties of hematopoietic stem cells.

Helfer BM, Balducci A, Sadeghi Z, O'Hanlon C, Hijaz A, Flask CA, Wesa A.

Cell Transplant. 2013;22(1):87-97. doi: 10.3727/096368912X653174. Epub 2012 Aug 2.

48.

Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease.

Fealy CE, Haus JM, Solomon TP, Pagadala M, Flask CA, McCullough AJ, Kirwan JP.

J Appl Physiol (1985). 2012 Jul;113(1):1-6. doi: 10.1152/japplphysiol.00127.2012. Epub 2012 May 10.

49.

Parallel excitation for B-field insensitive fat-saturation preparation.

Heilman JA, Derakhshan JD, Riffe MJ, Gudino N, Tkach J, Flask CA, Duerk JL, Griswold MA.

Magn Reson Med. 2012 Aug;68(2):631-8. doi: 10.1002/mrm.23238. Epub 2012 Jan 13.

50.

Assessing mitochondrial respiration in isolated hearts using (17)O MRS.

Lu M, Atthe B, Mateescu GD, Flask CA, Yu X.

NMR Biomed. 2012 Jun;25(6):883-9. doi: 10.1002/nbm.1807. Epub 2011 Dec 9.

Supplemental Content

Loading ...
Support Center